Small-cap pharma stock rallies 178% in 2026, extends winning run into fifth year; key factors behind rally
New Delhi, Sept. 29 -- Cupid, a consumer wellness and personal care company, has seen an explosive rally in its shares in 2026, recording multiple record highs and remaining on track to extend its annual winning run to five.
In the current year so far, the stock has gained 178% to reach Rs.288 apiece as investors rushed to add the scrip to their portfolios, buoyed by the company's growing order book and its ongoing expansion plans, which were started reflecting in its recent quarters and helped the stock defy the weak broader market.
This is not the first year that Cupid posted multibagger returns. Shareholders of the company were familiar with these kinds of gains, as the stock closed 2025 with a massive 584% surge. Prior to this, the ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.